Source: The Union

María Antonieta Gamarra, national director of Health Surveillance, pointed out that hydroxychloroquine and ivermectin are effective against the coronavirus, since they contribute to shorten the hospitalization times of the infected, although they should only be accessed under medical prescription. She underscored this after self-medication against COVID-19 has increased significantly.

“Hydroxychloroquine and ivermectin have long been available, but they are for use prescribed by the doctor on the patient with coronavirus. They are based on various protocols in other countries, ”Gamarra said in contact with La Unión, indicating that these two drugs, for oral use, are special for the treatment of people who are isolated at home.

In that order, he asserted that both hydroxychloroquine and ivermectin shorten hospitalization periods, exerting an effect on viral replication. “Their use must be under medical supervision because their effectiveness in terms of prevention and subsequent effects has not yet been proven,” she stated, noting that for that reason they are sold only by prescription.

He also spoke about remdisivir, which is an injectable exclusively for hospitalized coronavirus patients.

Gamarra regretted that self-medication around COVID-19 has notably increased, for which the Ministry of Health has launched a campaign against it.






Related:

100 doctors go to Brasilia to order hydroxychloroquine from popular pharmacies

Panama’s Ministry of Health: Covid-19 death toll decreased due to hydroxychloroquine use

President Jair Bolsonaro May Have Saved Thousands of Brazilian Lives

Infectologists propose to resume use of hydroxychloroquine in Panama

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »